pwalker on PROD1PC71 with NOTICES

9536 Federal Register / Vol. 72, No. 41 / Friday, March 2, 2007 / Notices 

The agenda will focus on the 

oversight of genetic testing, including 

the role of the private sector in assuring 

the quality and validity of genetic tests; 

the impact of gene patents and licensing 

practices on patient access to genetic 

technologies, including a progress 

report on the Committee’s study; and 

the status of Federal genetic information 

nondiscrimination legislation. The 

Committee will be briefed on the 

Secretary’s Personalized Health Care 

Initiative and the work of the American 

Health Information Community, 

particularly its Personalized Health Care 

Working Group. The Committee’s report 

on the Policy Issues Associated with 

Undertaking a New Large U.S. 

Population Cohort Project on Genes, 

Environment and Disease will be 

released at the meeting. There also will 

be updates on the Committee’s draft 

report on pharmacogenomics and 

several Federal initiatives and activities. 

Time will be provided each day for 

public comments. The Committee 

would welcome hearing from anyone 

wishing to provide public comment on 

any issue related to genetics, health and 

society. Individuals who would like to 

provide public comment should notify 

the SACGHS Executive Secretary, Ms. 

Sarah Carr, by telephone at 301–496– 

9838 or e-mail at sc112c@nih.gov. The 

SACGHS office is located at 6705 

Rockledge Drive, Suite 750, Bethesda, 

MD 20892. Anyone planning to attend 

the meeting, who is in need of special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, is also asked to 

contact the Executive Secretary. 

Under authority of 42 U.S.C. 217a, 

Section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

SACGHS to serve as a public forum for 

deliberations on the broad range of 

human health and societal issues raised 

by the development and use of genetic 

and genomic technologies and, as 

warranted, to provide advice on these 

issues. The draft meeting agenda and 

other information about SACGHS, 

including information about access to 

the Web cast, will be available at the 

following Web site: http:// 

www4.od.nih.gov/oba/sacghs.htm. 

Dated: February 22, 2007. 

Anna Snouffer, 

Acting Director, NIH Office of Federal 

Advisory Committee Policy. 

[FR Doc. 07–973 Filed 3–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institute for Occupational 

Safety and Health; Designation of a 

Class of Employees for Addition to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) gives notice of a 

decision to designate a class of 

employees at General Atomics in La 

Jolla, California, as an addition to the 

Special Exposure Cohort (SEC) under 

the Energy Employees Occupational 

Illness Compensation Program Act of 

2000. On February 16, 2007, the 

Secretary of HHS designated the 

following class of employees as an 

addition to the SEC: 

Atomic Weapons Employer (AWE) 

employees who were monitored or should 

have been monitored for exposure to ionizing 

radiation while working at the General 

Atomics facility in La Jolla, California at the 

following locations: Science Laboratories A, 

B, and C (Building 2); Experimental Building 

(Building 9); Maintenance (Building 10); 

Service Building (Building 11); Buildings 21 

and 22; Hot Cell Facility (Building 23); Waste 

Yard (Buildings 25 and 26); Experimental 

Area (Buildings 27 and 27–1); LINAC 

Complex (Building 30); HTGR–TCF (Building 

31); Fusion Building (Building 33); Fusion 

Doublet III (Building 34); SV–A (Building 

37); SV–B (Building 39); and SV–D (no 

building number) for a number of work days 

aggregating at least 250 work days from 

January 1, 1960, through December 31, 1969, 

or in combination with work days within the 

parameters established for one or more other 

classes of employees in the Special Exposure 

Cohort. 

This designation will become 

effective on March 18, 2007, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 513– 

533–6800 (this is not a toll-free 

number). Information requests can also 

be submitted by e-mail to 

OCAS@CDC.GOV. 

Dated: February 23, 2007. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 07–948 Filed 3–1–07; 8:45 am] 

BILLING CODE 4160–17–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institute for Occupational 

Safety and Health; Designation of a 

Class of Employees for Addition to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) gives notice of a 

decision to designate a class of 

employees at the Monsanto Chemical 

Company in Dayton, Ohio, as an 

addition to the Special Exposure Cohort 

(SEC) under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. On February 16, 

2007, the Secretary of HHS designated 

the following class of employees as an 

addition to the SEC: 

Atomic Weapons Employer (AWE) 

employees who were monitored or should 

have been monitored for exposure to ionizing 

radiation while working at Monsanto 

Chemical Company Units I, III, or IV in 

Dayton, Ohio, for a number of work days 

aggregating at least 250 work days during the 

period from January 1, 1943, through 

December 31, 1949, or in combination with 

work days within the parameters established 

for one or more other classes of employees 

in the Special Exposure Cohort. 

This designation will become 

effective on March 18, 2007, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 513– 

533–6800 (this is not a toll-free 

number). Information requests can also 

be submitted by e-mail to 

OCAS@CDC.GOV.